DLD Asset Management, LP - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 131 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
DLD Asset Management, LP ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$509,000100,0000.03%
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q1 2020.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders